Clinical Trial Update: Double-blind Study in Paediatric Epileptic to Compare the Subject Preference for ESL Suspension Formulation With Alternative Flavours [Phase 2]

View source ↗

Summary

Phase 2 double-blind study in pediatric epilepsy comparing subject flavor preference for an eslicarbazepine acetate suspension formulation (ESL) against alterna…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Epilepsy

Drugs mentioned

• eslicarbazepine acetate (eslicarbazepine acetate)

Snippet

Sponsor: Bial - Portela C S.A. | Conditions: Epilepsy | Phase 2 | Status: COMPLETED | Results posted: 2014-04-03